These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 16750322)
1. The importance of immunohistochemical expression of EGFr in squamous cell carcinoma of the oral cavity treated with surgery and postoperative radiotherapy. Smid EJ; Stoter TR; Bloemena E; Lafleur MV; Leemans CR; van der Waal I; Slotman BJ; Langendijk JA Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1323-9. PubMed ID: 16750322 [TBL] [Abstract][Full Text] [Related]
2. Biological markers and prognosis in recurrent oral cancer after salvage surgery. Agra IM; Carvalho AL; Pinto CA; Martins EP; Filho JG; Soares FA; Kowalski LP Arch Otolaryngol Head Neck Surg; 2008 Jul; 134(7):743-9. PubMed ID: 18645125 [TBL] [Abstract][Full Text] [Related]
3. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma. Eriksen JG; Steiniche T; Overgaard J; Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906 [TBL] [Abstract][Full Text] [Related]
4. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Smith BD; Smith GL; Carter D; DiGiovanna MP; Kasowitz KM; Sasaki CT; Haffty BG Arch Otolaryngol Head Neck Surg; 2001 Jul; 127(7):780-5. PubMed ID: 11448349 [TBL] [Abstract][Full Text] [Related]
5. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis. Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613 [TBL] [Abstract][Full Text] [Related]
6. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial. Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016 [TBL] [Abstract][Full Text] [Related]
7. Correlation among six biologic factors (p53, p21(WAF1), MIB-1, EGFR, HER2, and Bcl-2) and clinical outcomes after curative chemoradiation therapy in squamous cell cervical cancer. Yamashita H; Murakami N; Asari T; Okuma K; Ohtomo K; Nakagawa K Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1165-72. PubMed ID: 19101092 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of epidermal growth factor receptor immunoreactivity in squamous cell carcinoma of the oral mucosa. Maiorano E; Favia G; Maisonneuve P; Viale G J Pathol; 1998 Jun; 185(2):167-74. PubMed ID: 9713343 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma. Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial. Bentzen SM; Atasoy BM; Daley FM; Dische S; Richman PI; Saunders MI; Trott KR; Wilson GD J Clin Oncol; 2005 Aug; 23(24):5560-7. PubMed ID: 16110017 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of EGF receptor expression in early glottic cancer. Demiral AN; Sarioglu S; Birlik B; Sen M; Kinay M Auris Nasus Larynx; 2004 Dec; 31(4):417-24. PubMed ID: 15571917 [TBL] [Abstract][Full Text] [Related]
12. Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis. Psyrri A; Yu Z; Weinberger PM; Sasaki C; Haffty B; Camp R; Rimm D; Burtness BA Clin Cancer Res; 2005 Aug; 11(16):5856-62. PubMed ID: 16115926 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of vascular endothelial growth factor in squamous cell carcinomas of the tonsil in relation to human papillomavirus status and epidermal growth factor receptor. Fei J; Hong A; Dobbins TA; Jones D; Lee CS; Loo C; Al-Ghamdi M; Harnett GB; Clark J; O'Brien CJ; Rose B Ann Surg Oncol; 2009 Oct; 16(10):2908-17. PubMed ID: 19603236 [TBL] [Abstract][Full Text] [Related]
14. Squamous cell carcinoma of the buccal mucosa: an aggressive cancer requiring multimodality treatment. Lin CS; Jen YM; Cheng MF; Lin YS; Su WF; Hwang JM; Chang LP; Chao HL; Liu DW; Lin HY; Shum WY Head Neck; 2006 Feb; 28(2):150-7. PubMed ID: 16200628 [TBL] [Abstract][Full Text] [Related]
15. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome. Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865 [TBL] [Abstract][Full Text] [Related]
16. The prognostic significance of epidermal growth factor receptor expression in squamous cell carcinomas of the oesophagus. Torzewski M; Sarbia M; Verreet P; Bittinger F; Dutkowski P; Heep H; Willers R; Gabbert HE Anticancer Res; 1997; 17(5B):3915-9. PubMed ID: 9427803 [TBL] [Abstract][Full Text] [Related]
17. High expression of S-phase kinase-associated protein 2 (Skp2) is a strong prognostic marker in oral squamous cell carcinoma patients treated by UFT in combination with radiation. Harada K; Supriatno ; Kawaguchi S; Kawashima Y; Itashiki Y; Yoshida H; Sato M Anticancer Res; 2005; 25(3c):2471-5. PubMed ID: 16080478 [TBL] [Abstract][Full Text] [Related]
18. Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Preuss SF; Weinell A; Molitor M; Semrau R; Stenner M; Drebber U; Wedemeyer I; Hoffmann TK; Guntinas-Lichius O; Klussmann JP Head Neck; 2008 Oct; 30(10):1318-24. PubMed ID: 18704972 [TBL] [Abstract][Full Text] [Related]
19. [Prognostic factors and survival rates in oral cavity cancers]. Uğurluer G; Ozyurt SC; Aksaray F; Aslan N; Habiboğlu R; Tümöz M Kulak Burun Bogaz Ihtis Derg; 2006; 16(2):64-71. PubMed ID: 16763419 [TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor as a prognostic factor in locally advanced rectal-cancer patients treated with preoperative chemoradiation. Li S; Kim JS; Kim JM; Cho MJ; Yoon WH; Song KS; Yeo SG; Kim JS Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):705-12. PubMed ID: 16690221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]